Company

Travere Therapeutics, Inc.

Public · TVTXUnited States

Travere Therapeutics is a biotechnology company that identifies, develops, and delivers therapies for rare diseases. Based in San Diego with operations in Dublin and Switzerland, the company focuses on conditions like classical homocystinuria and other serious rare disorders. The company serves patients, families, and caregivers affected by rare diseases.

Travere Therapeutics, Inc. is a publicly traded company, based in the United States. It trades under the ticker TVTX. Leadership tracked by CEOInsider includes Bradley L. Campbell (CEO).

travere.com ↗LinkedIn ↗

Leadership

Current

Bradley L. Campbell

CEO

Recent developments

AI summary of recent coverage

Recent coverage has focused on Travere Therapeutics' leadership transition, with the company naming Bradley Campbell as chief executive officer effective December 1, 2026, following the announced planned departure of current CEO Eric Dube. The news has garnered attention across financial and industry media outlets, with some coverage noting stock movement in response to the executive change.

Summarized from the headlines in the sidebar; see each source for the full story.